e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Lumping and splitting of fibrotic interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Personalised pathogenetic pathways in fibrotic ILDs: the yin of pathogenetic thinking
M. Molina Molina (Barcelona, Spain)
Source:
International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Session:
Lumping and splitting of fibrotic interstitial lung diseases
Session type:
Symposium
Number:
3768
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Molina Molina (Barcelona, Spain). Personalised pathogenetic pathways in fibrotic ILDs: the yin of pathogenetic thinking. International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Pathogenetic mechanisms common to disease progression in fibrotic ILDs: the yang of pathogenetic thinking
Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Year: 2019
Lumping: are the commonalities among fibrosing ILDs more important than the differences?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019
Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012
Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007
Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015
The current classification of the idiopathic interstitial pneumonias: has it advanced pathogenetic understanding
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Pathogenesis and genetics of ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Approach to pathogenetic treatment of experimental pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 637s
Year: 2006
Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008
Cardiovascular disease: pathophysiological mechanisms
Source: Eur Respir Monogr 2015; 67: 37-50
Year: 2015
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
Year: 2019
The yin and yang of idiopathic pulmonary fibrosis
Source: Eur Respir J , 49 (2) 1602316; DOI: 10.1183/13993003.02316-2016
Year: 2017
The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?
Source: Eur Respir J 2010; 35: 730-734
Year: 2010
Some aspects of COPD ethiopathogenesis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD
Source: Eur Respir J, 55 (2) 1900563; 10.1183/13993003.00563-2019
Year: 2020
BOS/OB: aetiology and pathogenesis
Source: School Course 2012 - Lung Transplantation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept